DRKS00024086已完成不适用
Protecting against brain damage by improving treatment in neonates with hypoglycemia. - ProBrain-D
Heinrich-Heine Universität0 个研究点目标入组 957 人开始时间: 2021年1月15日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 957
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- one 至 11 Years（—）
- 性别
- All
入选标准
- •Newborns with and without hypoglycemia born at the University Hospital Düsseldorf between March 2018 - June 2022 or 2010 - 2015
排除标准
- •Lack of parental consent. Prematurity <35+0 weeks gestation.
- •Excluded for analysis of the primary endpoint are all children in whom another nonhyperglycemic cause of developmental disability is/will be known.
- •Patients receiving glycemic therapy (e.g., infusion/gastric tube during CPAP or similar) due to another clinical indication (not hypoglycemia) will remain in the study and may only be excluded from certain endpoints in the analysis.
研究者
相似试验
招募中
不适用
Prevention of cerebral lesions by improving the management of postnatal hypoglycemia and hyperinsulinismP70.0P70.1P70.4P70.8P70.9E16.1Syndrome of infant of mother with gestational diabetesSyndrome of infant of a diabetic motherOther neonatal hypoglycaemiaOther transitory disorders of carbohydrate metabolism of fetus and newbornTransitory disorder of carbohydrate metabolism of fetus and newborn, unspecifiedOther hypoglycaemiaDRKS00021474niversitätsklinikum Düsseldorf200
进行中（未招募）
1 期
A randomised controlled trial of neuroprotection with lamotrigine in secondary progressive multiple sclerosis - Neuroprotection with lamotrigine in multiple sclerosisMultiple sclerosisEUCTR2005-001949-42-GBniversity College London120
已完成
不适用
Schizophrenia Termination Of Pharmacotherapy: STOP-trialSchizophrenia, schizophreniform disorder, schizoaffective disorderMental and Behavioural DisordersSchizophreniaISRCTN06332944The Netherlands Organisation for Health Research and Development (ZonMw) (The Netherlands)20
已完成
2 期
Clinical study to assess treatment effects of Cerebrolysin in amyotrophic lateral sclerosisMotor neuron diseaseISRCTN38393880Instituto Cardiológico Banfield20
进行中（未招募）
4 期
Preventing stroke, premature death and cognitive decline in a broader community of patients with atrial fibrillation (DaRe2THINK)Circulatory SystemAtrial fibrillationISRCTN21157803niversity of Birmingham3,000